Acetazolamide encapsulation in elastin like recombinamers using a supercritical antisolvent (SAS) process for glaucoma treatment
Impact Factor. 2023 (2024 update): 5.3
Main Authors: | , , , , , , , |
---|---|
Other Authors: | |
Format: | info:eu-repo/semantics/publishedVersion |
Language: | eng |
Published: |
2024
|
Subjects: | |
Online Access: | http://hdl.handle.net/11086/553213 https://www.sciencedirect.com/science/article/abs/pii/S0378517324003326?via%3Dihub https://www.scopus.com/record/display.uri?eid=2-s2.0-85191178747&origin=inward&txGid=2e4211b9f2132817dba0230d9ebf6b5c https://pubmed.ncbi.nlm.nih.gov/38621614/ https://doi.org/10.1016/j.ijpharm.2024.124098 |
Internet
http://hdl.handle.net/11086/553213https://www.sciencedirect.com/science/article/abs/pii/S0378517324003326?via%3Dihub
https://www.scopus.com/record/display.uri?eid=2-s2.0-85191178747&origin=inward&txGid=2e4211b9f2132817dba0230d9ebf6b5c
https://pubmed.ncbi.nlm.nih.gov/38621614/
https://doi.org/10.1016/j.ijpharm.2024.124098